A potential new therapeutic system for glaucoma: Solid lipid nanoparticles containing methazolamide

Journal of Microencapsulation

Volumn 28, Issue 2, 2011, Pages 134-141

  Li, Rui ^a   Jiang, Sunmin ^a   Liu, Dongfei ^a   Bi, Xinyun ^a   Wang, Fengzhen ^a   Zhang, Qing ^a   Xu, Qunwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

emulsion solvent evaporation; intraocular pressure; Methazolamide; ocular delivery; ocular irritation; solid lipid nanoparticles

Indexed keywords

BRINZOLAMIDE; METHAZOLAMIDE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SOLUTION; EMULSION; EVAPORATION; EYE EXAMINATION; EYE IRRITATION; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; MEAN RESIDENCE TIME; NANOPHARMACEUTICS; NONHUMAN; OSMOTIC PRESSURE; PARTICLE SIZE; PH; PHARMACODYNAMICS; PHYSICAL CHEMISTRY; RABBIT; TIME TO MAXIMUM PLASMA CONCENTRATION; TOXICITY TESTING; ZETA POTENTIAL;

ANIMALS; CARBONIC ANHYDRASE INHIBITORS; DRUG DELIVERY SYSTEMS; FEMALE; GLAUCOMA; HUMANS; LIPIDS; MALE; METHAZOLAMIDE; NANOPARTICLES; RABBITS;

EID: 79251646878     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2010.539304     Document Type: Article

References (33)

1. Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for Dorzolamide Hydrochloride. AAPS Pharm Sci Tech, 2009;10:808-19.
2. Becker B. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox: A preliminary report. Am J Ophthalmol, 1954;37:13-5.
3. Chang JN. Apparatus and methods for implanting particulate ocular implants. 2006. US Patent 2007/0293873 A1, 19 June.
4. Das S, Suresh PK, Desmukh R. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine: NBM, 2010;6:318-23.
5. Draize JH, Woodard G, Calvery HO. Method for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther, 1944;82:377-90.
6. Fialho SL, da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Exp Ophthalmol, 2004;32:626-32.
7. Fridriksdottir H, Loftsson T, Stefansson E. Formulation and testing of methazolamide cyclodextrin eye drop solutions. J Control Release, 1997;44:95-9.
8. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacinloaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine: NBM, 2010;6:324-33.
9. Hagerstrom H, Paulsson M, Edsman K. Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur J Pharm Sci, 2000;9:301-9.
10. Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for Acetazolamide: In vitro and in vivo studies. AAPS Pharm Sci Tech, 2007;8: E1-E12.
11. Huo D, Deng S, Li L, Ji J. Studies on the poly (lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm, 2005;89:63-7.
12. Jonathan CJ, Norman BJ, McDonnell P. 1996. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent. US Patent 5494901, 27 February.
13. Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm, 2007;340:126-33.
14. Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular delivery: An overview. Int J Pharm, 2004;269:1-14.
15. Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: Future perspective in topical glaucoma therapeutics. Int J Pharm, 2002;248:1-14.
16. Le Bourlais C, Acar L, Zia H, Sado PA, Needham T, Leverge R. Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res, 1998;17:35-58.
17. Liu DF, Jiang SM, Shen H, Qin S, Liu JJ, Zhang Q, Li R, Xu QW. Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion/solvent evaporation method. J Nanopart Res, 2010; doi: 10.1007/s11051-010-9998-y.
18. Luo YF, Chen DW, Ren LX, Zhao XL, Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release, 2006;114:53-9.
19. Maren TH. Carbonic anhydrase: Chemistry, physiology, and inhibition. Physiol Rev, 1967;47:595-781.
20. Muller RH, Mehnert W, Lucks JS, Schwarz C, Zur Muhlen A, Weyhers H, Freitas C, Ruhl D. Solid lipid nanoparticles (SLN): An alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm, 1995;41:62-9.
21. Palma SD, Tartara LI, Quinteros D, Allemandi DA, Longhi MR, Granero GE. An efficient ternary complex of acetazolamide with HP-ß-CD and TEA for topical ocular administration. J Control Release, 2009;138:24-31.
22. Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofenloaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials, 2002;23:3247-55.
23. Schubert MA, Muller-Goymann CC. Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur J Pharm Biopharm, 2005;61:77-86.
24. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, Martone JF, Royall RM, Witt KA, Ezrine S. Racial differences in the cause-specific prevalence of blindness in east Baltimore. New Engl J Med, 1991;325:1412-17.
25. Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm, 2004;278:71-7.
26. Sultana Y, Jain R, Aqil M, Ali A. Review of ocular drug delivery. Curr Drug Deliv, 2006;3:207-17.
27. Vandamme TF. Microemulsions as ocular drug delivery systems: Recent developments and future challenges. Prog Retin Eye Res, 2002;21:15-34.
28. Wakiyama N, Juni K, Nakano M. Preparation and evaluation in vitro of polylactic acid microspheres containing local anaesthetics. Chem Pharm Bull, 1981;29:3363-8.
29. Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y. Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res, 2004;23:253-81.
30. Ye J, Wang Q, Zhou X, Zhang N. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm, 2008;352:273-9.
31. Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular drug delivery systems. Adv Drug Deliv Rev, 1995;16:61-73.
32. Zimmerman TJ. Acetazolamide and methazolamide. Ann Ophthalmol, 1978;10:509-10.
33. Zur Muhlen A, Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie, 1998;53:552-5. (Pubitemid 28376685)